273 related articles for article (PubMed ID: 29980381)
1. Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma.
Back M; Rodriguez M; Jayamanne D; Khasraw M; Lee A; Wheeler H
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):556-562. PubMed ID: 29980381
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
[TBL] [Abstract][Full Text] [Related]
3. [Revised WHO classification 2016 of gliomas : what's new ?].
Brouland JP; Hottinger AF
Rev Med Suisse; 2017 Oct; 13(579):1805-1809. PubMed ID: 29064198
[TBL] [Abstract][Full Text] [Related]
4. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
Malzkorn B; Reifenberger G
Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
[TBL] [Abstract][Full Text] [Related]
5. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
6. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
[TBL] [Abstract][Full Text] [Related]
7. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
8. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
10. 2016 World Health Organization Classification of Central Nervous System Tumors.
Wen PY; Huse JT
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1531-1547. PubMed ID: 29200109
[TBL] [Abstract][Full Text] [Related]
11. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
12. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation.
Sejda A; Grajkowska W; Trubicka J; Szutowicz E; Wojdacz T; Kloc W; Iżycka-Świeszewska E
Folia Neuropathol; 2022; 60(2):137-152. PubMed ID: 35950467
[TBL] [Abstract][Full Text] [Related]
13. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Komori T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
[TBL] [Abstract][Full Text] [Related]
14. Impact of the 2016 World Health Organization Classification of Tumours of the Central Nervous System: an Irish experience.
Fearon C; Loftus T; Byrne AL; Heffernan J; Cooney M; Heeney C; Walsh A; Lorigan J; Beausang A; Cryan J; Farrell M; Brett F
Ir J Med Sci; 2020 Aug; 189(3):799-803. PubMed ID: 31797204
[TBL] [Abstract][Full Text] [Related]
15. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
Nabors LB; Portnow J; Ammirati M; Baehring J; Brem H; Butowski N; Fenstermaker RA; Forsyth P; Hattangadi-Gluth J; Holdhoff M; Howard S; Junck L; Kaley T; Kumthekar P; Loeffler JS; Moots PL; Mrugala MM; Nagpal S; Pandey M; Parney I; Peters K; Puduvalli VK; Ragsdale J; Rockhill J; Rogers L; Rusthoven C; Shonka N; Shrieve DC; Sills AK; Swinnen LJ; Tsien C; Weiss S; Wen PY; Willmarth N; Bergman MA; Engh A
J Natl Compr Canc Netw; 2017 Nov; 15(11):1331-1345. PubMed ID: 29118226
[TBL] [Abstract][Full Text] [Related]
16. [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].
Feiden S; Feiden W
Pathologe; 2008 Nov; 29(6):411-21. PubMed ID: 18820922
[TBL] [Abstract][Full Text] [Related]
17. Integrated phenotype-genotype approach in diagnosis and classification of common central nervous system tumours.
Merve A; Millner TO; Marino S
Histopathology; 2019 Sep; 75(3):299-311. PubMed ID: 30820974
[TBL] [Abstract][Full Text] [Related]
18. Updates in the Neuoroimaging and WHO Classification of Primary CNS Gliomas: A Review of Current Terminology, Diagnosis, and Clinical Relevance From a Radiologic Prospective.
Colip C; Oztek MA; Lo S; Yuh W; Fink J
Top Magn Reson Imaging; 2019 Apr; 28(2):73-84. PubMed ID: 31022050
[TBL] [Abstract][Full Text] [Related]
19. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
